← Open Payments lookup

ERIN RUDIAK: Open Payments

NPI 1013540319 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,090 in 56 payments from 15 companies in 2025. Trend: 2023 $428 · 2024 $1,174 · 2025 $1,090

Food & beverage: $1,090
CompanyPaymentsAmount
Novo Nordisk Inc12$243
ABBVIE INC.14$229
PFIZER INC.7$139
AstraZeneca Pharmaceuticals LP5$103
Lilly USA, LLC4$80
Otsuka America Pharmaceutical, Inc.4$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Corcept Therapeutics1$25
Daiichi Sankyo Inc.1$23

Products named: Ozempic, NURTEC ODT, Wegovy, QULIPTA, KISUNLA, UBRELVY, VRAYLAR, REXULTI.

Industry payments across VA — which companies pay providers there.